SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-025975
Filing Date
2022-05-12
Accepted
2022-05-12 16:31:19
Documents
47
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0322_citiuspharm.htm   iXBRL 10-Q 580960
2 AMENDED AND RESTATED EMPLOYMENT AGREEMENT BETWEEN MYRON HOLUBIAK AND CITIUS PHAR f10q0322ex10-1_citiuspharma.htm EX-10.1 89252
3 CERTIFICATION f10q0322ex31-1_citiuspharma.htm EX-31.1 9023
4 CERTIFICATION f10q0322ex31-2_citiuspharma.htm EX-31.2 9173
5 CERTIFICATION f10q0322ex32-1_citiuspharma.htm EX-32.1 5236
  Complete submission text file 0001213900-22-025975.txt   3537171

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ctxr-20220331.xsd EX-101.SCH 43776
7 XBRL CALCULATION FILE ctxr-20220331_cal.xml EX-101.CAL 23896
8 XBRL DEFINITION FILE ctxr-20220331_def.xml EX-101.DEF 162563
9 XBRL LABEL FILE ctxr-20220331_lab.xml EX-101.LAB 351716
10 XBRL PRESENTATION FILE ctxr-20220331_pre.xml EX-101.PRE 173161
41 EXTRACTED XBRL INSTANCE DOCUMENT f10q0322_citiuspharm_htm.xml XML 387142
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38174 | Film No.: 22918355
SIC: 2834 Pharmaceutical Preparations